Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=WCJFBSYALHQBSK-UHFFFAOYSA-N
InChI=1S/C20H25NO/c1-4-19(22)20(15-16-21(2)3,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14H,4,15-16H2,1-3H3
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.rexall.ca/articles/view/1486/Cophylac
Sources: http://www.rexall.ca/articles/view/1486/Cophylac
Normethadone is a derivate of opioid analgetic methadone, used as component of antitussive drops in Canada. Illicit drug.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P33535|||Q64064 Gene ID: 25601.0 Gene Symbol: Oprm1 Target Organism: Rattus norvegicus (Rat) Sources: http://www.ncbi.nlm.nih.gov/pubmed/7602488 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Cophylac Approved UseCough |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.rexall.ca/articles/view/1486/Cophylac
Cophylac (normethadone HCl 10 mg and p-hydroxyephedrine HCl 20 mg): 15 drops twice daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:33:06 GMT 2023
by
admin
on
Fri Dec 15 16:33:06 GMT 2023
|
Record UNII |
KR2L2A68XL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9635
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
||
|
WHO-ATC |
R05DA06
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
||
|
WHO-VATC |
QR05DA06
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
32009
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID6057748
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
C76843
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
NORMETHADONE
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | Normethadone (INN, BAN; brand names Cophylac, Dacartil, Eucopon, Mepidon, Noramidone, Normedon, and others), also known as desmethylmethadone or phenyldimazone, is a synthetic opioid analgesic and antitussive agent.Normethadone is listed under the Single Convention on Narcotic Drugs 1961 and is an Schedule I Narcotic controlled substance in the United States, with a DEA ACSCN of 9635 and an annual manufacturing quota of 2 grams. | ||
|
1969
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
KR2L2A68XL
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
19598
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
467
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
207-401-1
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
SUB09376MIG
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
m8068
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
467-85-6
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
100000083620
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
10090
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
DB11609
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
C005845
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL346331
Created by
admin on Fri Dec 15 16:33:06 GMT 2023 , Edited by admin on Fri Dec 15 16:33:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
PARENT -> SALT/SOLVATE | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |